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Capsular serovars of virulent
Capnocytophaga canimorsus are shared
by the closely related species C. canis
and C. cynodegmi
Francesco Renzi 1, Estelle Hess1, Melanie Dol1, Dunia Koudad1, Elodie Carlier1, Maria Ohlén2,
Edward Moore2,3 and Guy Richard Cornelis1
Abstract
Capnocytophaga canimorsus is a dog oral commensal bacterium that causes rare but life-threatening generalized
infections in humans who have been in contact with its animal hosts. Two other dog commensals, Capnocytophaga
canis and Capnocytophaga cynodegmi, cause rare, mild local infections. To date, nine capsular serovars have been
described in C. canimorsus. Here, we serotyped 112 strains of Capnocytophaga spp. isolated from human infections.
The C. canimorsus strains (86 of 96, 89.6%) belonged to serovars A, B, or C with relative frequencies of approximately
30% for each serovar. The high prevalence of the A, B, and C serovars in strains isolated from humans, compared to the
previously described low prevalence of these serovars among dog isolates (7.6%), confirms that these three serovars
are more virulent to humans than other serovars and suggests that the low incidence of disease may be linked to the
low prevalence of the A, B, and C serovars in dogs. We serotyped six strains of C. canis and ten strains of C. cynodegmi
and, surprisingly, found one C. canis and three C. cynodegmi strains to be of capsular serovar B. This observation
prompted us to test 34 dog-isolated C. canis and 16 dog-isolated C. cynodegmi strains. We found four C. canis strains
belonging to serovar A and one belonging to serovar F. In contrast, no dog-isolated C. cynodegmi strain could be
typed with the available antisera. This work demonstrates that virulence-associated capsular polysaccharides (A, B, and
C) are not specific to the C. canimorsus species.
Introduction
Capnocytophaga is a Gram-negative bacterial genus in
the phylum Bacteroidetes that represents part of the
normal oral flora of domestic animals and humans1.
Four Capnocytophaga species are present in dog and cat
oral cavities: C. canimorsus; C. cynodegmi; C. canis; and
C. stomatis2–4. C. cynodegmi, C. canis, and C. stomatis are
associated with human mild wound infections, although,
recently, one case of C. canis-mediated sepsis was
described5. In contrast, C. canimorsus has been known
since 1961 to cause severe generalized infections in
patients who have been bitten, scratched, or simply in
contact with dogs and cats6–8. Despite the administration
of adequate antibiotherapy, C. canimorsus-induced septi-
cemia may evolve to septic shock with mortality as high
as 30% and debilitating morbidity in survivors6.
Several predisposing factors for infection have been
identified in C. canimorsus-infected patients, such as
splenectomy, alcohol abuse, smoking and advanced age,
although as many as 40% of patients did not present any
obvious risk factor9, implying that C. canimorsus cannot
solely be considered an opportunistic pathogen. To date,
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more than 500 cases of human infections have been
reported. Two studies have reported an incidence of
0.5–0.7 cases per million inhabitants per year10,11,
although, in 2016, a retrospective study performed in
the Helsinki area in Finland reported an incidence of
4.1 cases per million inhabitants per year12. The dis-
crepancy between these estimates might result from the
difficulty in diagnosing C. canimorsus infections, pre-
sumably because of the slow and fastidious growth of
these bacteria in culture2.
Recently, we reported the discovery of a capsular poly-
saccharide at the surface of C. canimorsus cells, composed
of the same polysaccharide units as the lipooligosacchar-
ide O-antigen13. While the repertoire of capsular serovars
is extensive among strains isolated from dog mouths,
three serovars, named A, B, and C, are predominant,
worldwide, among human infections14. Here, to further
investigate the correlation between capsular serovars and
virulence, we serotyped the Capnocytophaga strains
obtained from the Culture Collection University of
Gothenburg (CCUG), the largest collection of strains of
Capnocytophaga spp. isolated from human infections.
Our study confirms the high prevalence of capsular ser-
ovars A, B, and C among the strains of C. canimorsus
isolated from human infections (86/96, 89.6%), and we
describe two new serovars (L and M). The CCUG col-
lection contains six human-isolated C. canis and nine C.
cynodegmi strains. One C. canis strain turned out to
belong to serovar B, as did three C. cynodegmi strains.
This unexpected finding prompted us to test our collec-
tion of 34 C. canis strains isolated from dog mouths, and
we found that four strains belonged to serovar A and one
to serovar F.
Thus, our study confirms the higher virulence of
capsular serovars A, B, and C of C. canimorsus, but also
shows that serovars A, B, and F, and presumably others,
described in C. canimorsus can be found in C. canis
and C. cynodegmi.
Results
Capsular typing of human-isolated C. canimorsus strains
Since the C. canis species has been only recently
described3–5, we tested whether any of the 102 strains
from the CCUG identified as C. canimorsus might be
reclassified as C. canis. To this end, we sequenced the
PCR-amplified 16S rRNA genes (16S rDNAs) of these
102 strains and generated a dendrogram of their esti-
mated phylogenetic relationships (Fig. 1). The dendro-
gram clearly showed that 96 strains (94.1%) clustered with
the C. canimorsus type strain (ATCC 35979), while six
strains (5.9%) clustered with the C. canis type strain
(CcD38= LMG 29146) (Fig. 1). According to the 16S
rDNA phylogenetic analysis, these six strains were, thus,
reclassified as C. canis (Supplementary Table S1). We
then subjected the 96 C. canimorsus sensu stricto strains
to the PCR test designed to detect the three A, B, and C
capsular serovars14. These analyses showed that 87 of the
96 strains were positive and could be further typed as
either A, B, or C by serovar-specific PCRs (Table 1 and
Supplementary Fig. S1a–d). To confirm these results, we
performed Western blot analyses on polysaccharide
extracts of the 87 strains, using antisera specifically
recognizing the A, B, or C capsular serovars (Table 1 and
Supplementary Fig. S2a–c). This experiment confirmed
the PCR typing results and identifications for all strains
tested except for strain G58, which was found to belong to
the B serovar by PCR but did not react with the B anti-
serum. In summary, 86 of the 96 C. canimorsus strains
tested (89.58%) belonged to either serovars A (30/96,
31.3%), B (28/96, 29.2%), or C (28/96, 29.2%). Next, we
tested all strains by PCRs detecting the D and E capsular
types14. According to these analyses, seven strains
belonged to serovar D and none to serovar E (Table 1 and
Supplementary Fig. S1e, f), which was confirmed by
Western blot (Supplementary Fig. S2d). We then tested
the three strains that we could not type by the A-E PCRs
(G06, G45, and G58) using Western blot for all the cap-
sular types (A–I) we identified in previous studies14. None
of the strains reacted with these antisera (Supplementary
Fig. S2a–i). Three rabbit antisera were thus raised against
the G06, G45, and G58 whole bacteria and adsorbed (see
Methods). The anti-G06 antiserum strongly recognized
the capsule of the G06 strain (Supplementary Fig. S2j).
The anti-G58 serum recognized only the capsule of G58
(Supplementary Fig. S2k). Surprisingly, a Western blot
analysis of a polysaccharide sample of strain G45 with
G45 antiserum did not show any capsule for this strain
(Supplementary Fig. S2l). Thus, we identified two new
serovars that we named L (G06) and M (G58), and we
found a strain without a capsule. The capsular typing
results are summarized in Fig. 2. In short, we found that
the 96 C. canimorsus strains from the CCUG belonged to
only six serovars, with A, B, and C being heavily dominant
(89.6%), followed by the D serovar (7.3%) (Fig. 2a). These
results are in line with those previously observed for a
collection of 25 strains isolated worldwide from human
infections (Fig. 2a, b)14, with the only difference being that
none of the CCUG strains belonged to the E serovar and
one strain was non-capsulated.
Screening of dog-isolated C. canimorsus strains for the
presence of the L and M capsular serovars
We tested the prevalence of the new L and M capsular
serovars in a collection of 52 C. canimorsus strains iso-
lated from the mouths of dogs from Switzerland and
Belgium3,14 by an ELISA. Two strains, one isolated in
Switzerland and one isolated in Belgium, were found to
react with the anti-L sera (CcD20 and CcD106), while
Renzi et al. Emerging Microbes & Infections  (2018) 7:124 Page 2 of 12
Fig. 1 16S rDNA majority consensus tree of CCUG clinical strains. Flavobacterium johnsoniae (accession number M59051) was selected as an
outgroup (software: RDP Tree Builder)
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Table 1 Capsular typing of 96 human-isolated C. canimorsus strains from the CCUG collection
Strain PCR typing WB typing
ABC A B C D E Serovar A B C D E F G H I Serovar
G01 + + + − − − A + nd nd nd nd nd nd nd nd A
G02 + + − + − − A + nd nd nd nd nd nd nd nd A
G03 + − + − − − B nd + nd nd nd nd nd nd nd B
G04 + + + − − − A + nd nd nd nd nd nd nd nd A
G06 − − − − − − nt − − − − − − − − − nt
G07 + − + − − − B nd + nd nd nd nd nd nd nd B
G09 + − + − − − B nd + nd nd nd nd nd nd nd B
G11 + + + − − − A + nd nd nd nd nd nd nd nd A
G12 + − + − − − B nd + nd nd nd nd nd nd nd B
G16 + − + − − − B nd + nd nd nd nd nd nd nd B
G18 + − − + − − C nd nd + nd nd nd nd nd nd C
G20 + − − + − − C nd nd + nd nd nd nd nd nd C
G22 + − − + − − C nd nd + nd nd nd nd nd nd C
G23 + − − + − − C nd nd + nd nd nd nd nd nd C
G24 + + + − − − A + nd nd nd nd nd nd nd nd A
G26 + − − + − − C nd nd + nd nd nd nd nd nd C
G27 − − − − + − D nd nd nd + nd nd nd nd nd D
G28 + − + − − − B nd + nd nd nd nd nd nd nd B
G29 + − − + − − C nd nd + nd nd nd nd nd nd C
G30 + − + − − − B nd + nd nd nd nd nd nd nd B
G31 + − + − − − B nd + nd nd nd nd nd nd nd B
G33 + − + − − − B nd + nd nd nd nd nd nd nd B
G34 + + + − − − A + nd nd nd nd nd nd nd nd A
G35 + + + − − − A + nd nd nd nd nd nd nd nd A
G37 + − − + − − C nd nd + nd nd nd nd nd nd C
G38 + + − + − − A + nd nd nd nd nd nd nd nd A
G39 + − − + − − C nd nd + nd nd nd nd nd nd C
G40 + + − + − − A + nd nd nd nd nd nd nd nd A
G41 + + + − − − A + nd nd nd nd nd nd nd nd A
G43 + − − + − − C nd nd + nd nd nd nd nd nd C
G44 + − + − − − B nd + nd nd nd nd nd nd nd B
G45 − − − − − − nt − − − − − − − − − nt
G46 + − − + − − C nd nd + nd nd nd nd nd nd C
G47 + + + − − − A + nd nd nd nd nd nd nd nd A
G48 + − + − − − B nd + nd nd nd nd nd nd nd B
G49 + − + − − − B nd + nd nd nd nd nd nd nd B
G50 + − − + − − C nd nd nd nd nd nd nd nd nd C
G51 + − + − − − B nd + + nd nd nd nd nd nd B
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Table 1 continued
Strain PCR typing WB typing
ABC A B C D E Serovar A B C D E F G H I Serovar
G52 + − + − − − B nd + nd nd nd nd nd nd nd B
G54 + + − + − − A + nd nd nd nd nd nd nd nd A
G56 + − − + − − C nd nd + nd nd nd nd nd nd C
G57 + − + − − − B nd + nd nd nd nd nd nd nd B
G58 + − + − − − B − − − − − − − − − nt
G59 + + + − − − A + nd nd nd nd nd nd nd nd A
G60 + − + − − − B nd + nd nd nd nd nd nd nd B
G61 + − + − − − B nd + nd nd nd nd nd nd nd B
G63 + − + − − − B nd + nd nd nd nd nd nd nd B
G64 + + + − − − A + nd nd nd nd nd nd nd nd A
G65 + − + − − − B nd + nd nd nd nd nd nd nd B
G66 − − − − + − D nd nd nd + nd nd nd nd nd D
G67 + + − + − − A + nd nd nd nd nd nd nd nd A
G68 + + − + − − A + nd nd nd nd nd nd nd nd A
G69 + − − + − − C nd nd + nd nd nd nd nd nd C
G70 + − − + − − C nd nd + nd nd nd nd nd nd C
G71 + − − + − − C nd nd + nd nd nd nd nd nd C
G72 + − + − − − B nd + nd nd nd nd nd nd nd B
G73 + + + − − − A + nd nd nd nd nd nd nd nd A
G75 + − + − − − B nd + nd nd nd nd nd nd nd B
G76 + + − + − − A + nd nd nd nd nd nd nd nd A
G79 + − − + − − C nd nd + nd nd nd nd nd nd C
G80 + − − + − − C nd nd + nd nd nd nd nd nd C
G81 + − − + − − C nd nd + nd nd nd nd nd nd C
G82 + − − + − − C nd nd + nd nd nd nd nd nd C
G83 + + + − − − A + nd nd nd nd nd nd nd nd A
G85 + + + − − − A + nd nd nd nd nd nd nd nd A
G86 − − − − + − D nd nd nd + nd nd nd nd nd D
G88 + − − + − − C nd nd + nd nd nd nd nd nd C
G90 − − − − + − D nd nd nd + nd nd nd nd nd D
G91 + + + − − − A + nd nd nd nd nd nd nd nd A
G92 + + + − − − A + nd nd nd nd nd nd nd nd A
G93 + + + − − − A + nd nd nd nd nd nd nd nd A
G94 + − − + − − C nd nd + nd nd nd nd nd nd C
G95 + − + − − − B nd + nd nd nd nd nd nd nd B
G96 + − − + − − C nd nd + nd nd nd nd nd nd C
G97 + − + − − − B nd + nd nd nd nd nd nd nd B
G98 + + + − − − A + nd nd nd nd nd nd nd nd A
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none reacted with the anti-M sera (Supplementary
Table S3). These results were confirmed by Western blot
analysis of polysaccharidic structures (Supplementary
Fig. S3). This experiment showed that capsular serovar L
is not limited to Scandinavia.
Capsular typing of C. canis strains isolated from human
infections reveals the presence of a serovar B strain
As mentioned above, the strains of Capnocytophaga
spp. in this study that were isolated from human clinical
samples included six C. canis strains (Fig. 1 and Supple-
mentary Table S1). This finding may seem odd because C.
canis was described initially as a non-pathogenic species3,
although, since then, a few cases of human infections from
C. canis have been reported. Zangenah et al. reported the
isolation of a C. canis from a wound caused by a cat bite,
and Taki et al. recently described a human septicemia
after a cat bite4,5. It was, thus, not completely unexpected
to find some C. canis among the collection of clinical
strains, although the limited number of C. canis strains (6)
compared to the high number of C. canimorsus (96)
strains in the strain collection indicates that C. canis is far
less involved in human infections than C. canimorsus.
The majority of C. canis strains isolated from dogs lack
several factors that might contribute to C. canimorsus
pathogenicity, such as the ability to acquire iron from
transferrin and proliferate in human serum, as well as
the capacity to deglycosylate host glycoproteins and
cytochrome-oxidase activity3. However, Zangenah et al.
and Taki et al. reported that the C. canis isolates that
caused human infections are endowed with cytochrome-
oxidase activity, thus suggesting that these strains differ
from the majority of C. canis strains found in dog mouths.
We tested for oxidase activity in the six C. canis strains
isolated from human clinical samples and observed two
of them (G05 and G17) to be positive (data not shown).
Given the close relationship between C. canimorsus
and C. canis, we assessed whether other factors, such as
Table 1 continued
Strain PCR typing WB typing
ABC A B C D E Serovar A B C D E F G H I Serovar
G99 − − − − + − D nd nd nd + nd nd nd nd nd D
G100 + − − + − − C nd nd + nd nd nd nd nd nd C
G101 + + + − − − A + nd nd nd nd nd nd nd nd A
G102 + − + − − − B nd + nd nd nd nd nd nd nd B
G103 + − − + − − C nd nd + nd nd nd nd nd nd C
G104 + − + − − − B nd + nd nd nd nd nd nd nd B
G106 − − − − + − D nd nd nd + nd nd nd nd nd D
G108 + + − + − − A + nd nd nd nd nd nd nd nd A
G109 + + + − − − A + nd nd nd nd nd nd nd nd A
G110 + − − + − − C nd nd + nd nd nd nd nd nd C
G112 + + + − − − A + nd nd nd nd nd nd nd nd A
G113 + − + − − − B nd + nd nd nd nd nd nd nd B
G114 + + + − − − A + nd nd nd nd nd nd nd nd A
G115 + − + − − − B nd + nd nd nd nd nd nd nd B
G116 + + + − − − A + nd nd nd nd nd nd nd nd A
G117 + − − + − − C nd nd + nd nd nd nd nd nd C
G118 + − − + − − C nd nd + nd nd nd nd nd nd C
G119 + − − + − − C nd nd + nd nd nd nd nd nd C
G120 + − + − − − B nd + nd nd nd nd nd nd nd B
G121 − − − − + − D nd nd nd + nd nd nd nd nd D
Capsular typing was determined by PCR using the oligonucleotides given in Supplementary Table S2. The results were interpreted as previously described14: strains
positive for PCR A, PCR A and PCR B or PCR A and PCR C were typed as A, strains positive for only PCR B were typed as B, and strains positive for only PCR C as C.
Western blot analysis on polysaccharidic structures was performed using specific polyclonal rabbit antisera. nd not determined, nt non-typable
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capsular serovars, might be shared between these two
species and, in particular, among the clinical C. canis
strains; we, thus, tested the six strains of C. canis isolated
from human clinical samples for the presence of
C. canimorsus capsular serovars by PCR, using the pri-
mers for serovars ABC, D, and E. Three strains out of six
gave a positive result for the ABC PCR (G05, G36, and
G77), but two of them (G36 and G77) could not be typed
further by PCR using the A-specific, B-specific, and C-
specific primers or by Western blot using the specific
antisera. G05 was identified as serovar B (Table 2 and
Supplementary Fig. S4a–f), and this result was confirmed
by a Western blot analysis (Table 2 and Supplementary
Fig. S5a). The remaining three C. canis strains were tested
by Western blot for the presence of capsular serovars, but
none of them reacted with any of the sera (Supplementary
Fig. S5b–l). The finding that one of the C. canis human
clinical strains (G05) has a C. canimorsus serovar B
capsule is of great interest, since it shows for the first time
that capsular serovar B is shared between these two clo-
sely related species. Interestingly, strain G05 is also
oxidase-positive, thus suggesting that it might be more
virulent than most C. canis strains, since it possesses these
two factors. It is also of interest that one strain (G36) was
isolated from a patient who had been bitten by a cat. This
is the only cat-transmitted strain we have in our collec-
tions of human isolates.
C. canis isolated from dogs includes serovar A strains
We also assessed whether other C. canimorsus capsular
serovars might be shared by C. canis; we screened by PCR
and ELISA our C. canis collection of 34 strains isolated
from healthy dogs3. Four isolates (CcD7, CcD11, CcD46,
and CcD111) were identified as capsular serovar A, and
one (CcD123) was serovar F (Supplementary Fig. S6 and
Table 3). None of the other strains of C. canis reacted with
any of the tested sera (Table 3). We confirmed the pre-
sence of the capsular serovars A and F by Western blot
analyses (Supplementary Fig. S7). Our data, thus, showed
that, in addition to the serovar B capsule, C. canis can also
be endowed with capsules of serovar A (four strains of 34)
and of serovar F (one strain of 34). The four serovar A
Fig. 2 Prevalence of capsular serovars in C. canimorsus strains. Capsular serovar prevalence in human-isolated C. canimorsus strains from the
CCUG collection (a), UNamur collection (b), and CCUG and UNamur collections (c). Capsular serovar prevalence in dog-isolated C. canimorsus strains
(d). The data presented in b and d were partially previously published14
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strains are oxidase-negative, while the serovar F strain is
oxidase-positive3.
Capsular serovar B is also found in C. cynodegmi human
isolates
The finding that C. canis strains may have capsules of
the same serovars that identify more virulent C. cani-
morsus strains raised the question of whether C. cyno-
degmi, another closely related species, might also have
capsules of these C. canimorsus serovars. We tested 10
C. cynodegmi strains isolated from human infections and
16 C. cynodegmi strains isolated from healthy dogs
(Supplementary Figs. S8, S9, S10) by PCR and Western
blot. As summarized in Table 4, three of the 10 C. cyno-
degmi strains isolated from human infections were found
to possess serovar B capsules (Supplementary Fig. S9).
The remaining 7 human-isolated strains and the 16 dog-
isolated strains could not be typed with the 11 C. cani-
morsus antisera (Table 4, Supplementary Figs. S9, S10). In
conclusion, our data show that C. cynodegmi, as well as C.
canis, may share capsule serovar B.
Discussion
In our previous work, we showed that C. canimorsus is
endowed with capsular polysaccharides and that the
majority of human-isolated strains exhibit capsule type A,
B, or C, suggesting that these three capsular serovars are
more virulent to humans13,14. In this study, we confirmed
the prevalence of C. canimorsus capsular serovars A, B,
and C in a larger collection of human-isolated strains.
Among the 102 strains within the CCUG, 16S rDNA
sequence analyses showed that 96 were C. canimorsus
sensu stricto, while 6 belonged to the closely related spe-
cies C. canis; the misclassifications were due to the
recognition of C. canis as a distinct species 26 years after
the valid publication of C. canimorsus2,3. Serotyping the
96 C. canimorsus strains confirmed the prevalence of
capsular serovars A, B, and C in strains isolated from
human infections, with 86 of 96 strains (89.6%) belonging
to these three serovars, with approximately 30% of each
serovar. No significant difference was found in the pre-
valence of the A, B, and C serovars (Fisher’s exact test,
with significance levels of p < 0.05, p= 0.2441 for A, p= 1
for B, and p= 0.589 for C) between the human-isolated
C. canimorsus of the CCUG collection and the previously
studied collection of strains isolated worldwide14. These
data also confirmed that there are significantly more
strains belonging to serovars A, B, and C among human
isolates than among dog isolates (7.6%), confirming that
these three serovars are more virulent than any of the
others (Fig. 2c, d). In addition, our study confirms that the
A, B, and C serovars are not restricted to one geographical
area. In addition to the serovar A, B, and C strains, the
CCUG collection contained seven (7.3%) C. canimorsus
strains of serovar D. These data are in agreement with the
finding that the D serovar is the fourth most prevalent
serovar among C. canimorsus human isolates14. Thus,
although they represent only 7–8% (ref. 14 and this study)
of the human clinical isolates, serovar D strains should be
considered to be virulent and considered for prophylaxis.
In contrast to our previous findings14, we could not detect
any serovar E strain among the CCUG collection,
although we discovered two new capsular serovars, L and
M, each with a limited (1%) prevalence in human infec-
tions. We also found one non-capsulated strain among
the CCUG collection. Unfortunately, due to the lack of
clinical data regarding the patients from whom all CCUG
strains were isolated, at this point, we cannot draw any
conclusions regarding correlation of the severity of the
disease with the capsular serovars. Nevertheless, the
present study confirms that serovars other than A–D may
cause human infection but with a very low frequency.
These serovars may be less virulent and infectious only for
immunocompromised patients, although we have no data
to test this hypothesis here. We also tested the two new
L and M antisera against the collection of strains isolated
Table 2 Capsular typing of six human-isolated C. canis strains from the CCUG collection
Strain PCR typing WB typing
ABC A B C D E Serovar A B C D E F G H I L M Serovar
G05 + − + − − − B nd + nd nd nd nd nd nd nd nd nd B
G15 − − − − − − nt − − − − − − − − − − − nt
G17 − − − − − − nt − − − − − − − − − − − nt
G36 + − − − − − nt − − − − − − − − − − − nt
G42 − − − − − − nt − − − − − − − − − − − nt
G77 + − − − − − nt − − − − − − − − − − − nt
Capsular typing was determined by PCR using the oligonucleotides given in Supplementary Table S2. The results were interpreted as indicated in ref. 14: strains
positive for PCR A, PCR A and PCR B or PCR A and PCR C were typed as A, strains positive for only PCR B were typed as B, and strains positive for only PCR C as C.
Western blot analysis on polysaccharidic structures was performed using specific polyclonal rabbit antisera. nd not determined, nt non-typable
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ABC A B C D E Serovar A B C D E F G H I L M Serovar A F Serovar
1 − − − − − − nt 7.3 6.5 12.4 14.7 11.8 14.6 15.4 9.5 12.9 9.6 8.3 nt nd nd nt
4 − − − − − − nt 6.1 6.0 12.8 16.1 9.26 14.7 15.4 9.9 11.8 10.3 7.9 nt nd nd nt
7 + + − − − − A 102.6 8.6 10.8 13.8 9.76 13.2 15.1 10.6 10.4 9.1 7.3 A + nd A
11 + + − − − − A 99.0 6.9 9.98 14.4 9.35 12.8 14.9 10.3 11.1 8.8 7.3 A + nd A
15 − − − − − − nt 9.6 6.9 10.2 12.9 8.85 12.7 14.5 9.8 10.2 9.9 7.8 nt nd nd nt
36 − − − − − − nt 12.3 6.0 11.8 13.5 9.35 13.5 14.3 9.3 10.6 9.5 8.0 nt nd nd nt
38 − − − − − − nt 8.7 6.2 11.5 14.3 9.93 14.6 14.5 10.1 11.1 11.1 9.2 nt nd nd nt
46 + + − − − − A 96.7 6.4 11.3 13.5 9.10 12.2 14.0 8.7 9.8 11.6 8.5 A + nd A
50 − − − − − − nt 8.7 6.7 10.9 12.1 8.77 11.9 13.4 8.7 8.8 9.0 7.3 nt nd nd nt
54 − − − − − − nt 9.3 5.8 8.09 15.3 9.14 14.5 16.3 12.8 10.8 7.9 5.7 nt nd nd nt
64 − − − − − − nt 9.0 6.6 11.0 14.1 10.1 14.3 15.0 10.1 10.7 8.7 6.9 nt nd nd nt
66 − − − − − − nt 11.7 6.7 11.2 13.9 10.3 13.7 14.8 9.5 11.0 8.8 7.6 nt nd nd nt
75 − − − − − − nt 9.2 6.9 10.7 12.9 9.76 12.5 15.7 9.3 9.6 9.4 7.9 nt nd nd nt
79 − − − − − − nt 8.9 6.0 10.3 13.8 9.39 15.2 15.6 9.6 10.1 9.5 7.8 nt nd nd nt
82 − − − − − − nt 9.1 6.8 10.0 15.2 11.3 13.1 15.1 9.8 11.0 9.1 7.2 nt nd nd nt
85 − − − − − − nt 11.6 6.2 9.5 13.2 10.2 14.1 14.9 9.7 11.1 8.5 6.9 nt nd nd nt
88 − − − − − − nt 10.3 6.2 10.6 12.8 10.2 13.1 14.3 8.8 10.3 10.2 7.6 nt nd nd nt
93 − − − − − − nt 6.7 5.7 12.7 14.7 9.8 13.3 14.8 9.4 10.6 9.8 7.6 nt nd nd nt
94 − − − − − − nt 8.2 6.76 8.63 12.81 9.31 12.6 13.7 9.6 10.2 6.8 5.8 nt nd nd nt
95 − − − − − − nt 7.1 6.3 10.6 14.1 9.14 12.8 15.0 9.9 10.1 19.8 7.6 nt nd nd nt
97 − − − − − − nt 6.7 6.6 10.7 13.5 9.02 13.8 15.7 9.8 9.8 9.9 8.2 nt nd nd nt
102 − − − − − − nt 10.5 6.0 9.44 14.9 9.31 14.1 16.8 11.0 10.4 8.7 6.1 nt nd nd nt
103 − − − − − − nt 7.7 9.6 8.57 15.3 10.8 14.4 16.5 10.8 10.9 9.5 7.0 nt nd nd nt
108 − − − − − − nt 9.6 7.6 9.20 14.55 9.51 12.3 13.8 9.1 8.8 7.8 7.2 nt nd nd nt
109 − − − − − − nt 7.9 6.5 10.1 13.0 10.14 12.5 15.1 8.7 9.2 10.0 7.4 nt nd nd nt
110 − − − − − − nt 8.0 5.7 10.5 17 9.89 13.6 14.7 9.4 9.9 7.8 6.7 nt nd nd nt
111 + + − − − − A 104.5 9.4 10.4 14.7 10.6 13.4 16.3 10.4 11.3 9.5 7.0 A + nd A
112 − − − − − − nt 7.1 6.5 9.32 15.5 9.47 12.1 14.1 9.3 10.3 8.8 6.7 nt nd nd nt
114 − − − − − − nt 8.9 6.8 11.4 15 9.85 13.4 16.2 9.8 9.9 11.3 7.7 nt nd nd nt
121 − − − − − − nt 8.1 6.3 11.4 15.1 9.51 11.6 14.9 9.6 10.7 9.5 7.5 nt nd nd nt
123 − − − − − − nt 10.3 9.2 7.3 21.9 9.16 81.2 13.7 12.0 10.7 21.4 10.3 F nd + F
125 − − − − − − nt 7.4 7.8 11.1 13.8 7.29 12.5 15.4 13.3 9.0 8.2 6.5 nt nd nd nt
127 − − − − − − nt 8.1 7.1 12.5 18.9 7.87 12.1 14.2 12.4 9.9 8.8 7.9 nt nd nd nt
128 − − − − − − nt 7.4 16.8 12.3 13. 6.9 11.2 13.4 10.8 10.6 9.1 7.9 nt nd nd nt
Capsular typing was determined by PCR using the oligonucleotides given in Supplementary Table S2. The results were interpreted as indicated in ref. 14: strains
positive for PCR A, PCR A and PCR B or PCR A and PCR C were typed as A, strains positive for only PCR B were typed as B, and strains positive for only PCR C as
C. Capsular serotyping was determined by ELISA on entire heat-killed bacteria using specific polyclonal rabbit antisera. The readout of the ELISA was absorbance, but
the results are expressed here as percentage of reactivity calculated with respect to the absorbance value obtained for the capsular type strain. Values are expressed
as the means. Isolates with high reactivities are in bold. Western blot analysis on polysaccharidic structures was performed using specific polyclonal rabbit antisera. nd
not determined, nt non-typable
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from Swiss and Belgian dogs3 and found two Swiss
C. canimorsus strains endowed with an L-type capsule.
Thus, as we have shown before14, the serovars are inter-
nationally distributed. With 11 C. canimorsus serovars
(A–M) characterized to date, we can type only 38.5%
of the dog-isolated strains of our collection (20 of 52),
thus reinforcing a hypothesis of the existence of a
large repertoire of capsular serovars in dog-hosted
C. canimorsus.
C. canis was originally isolated from healthy dogs and
presumed to be a non-pathogenic species because it was
found exclusively in dogs and not among the strains of
Capnocytophaga spp. isolated from severe human infec-
tions. In addition, C. canis strains are missing several
factors that are suspected to contribute to C. canimorsus
pathogenicity, such as the ability to acquire iron from
transferrin and proliferate in human serum, as well as the
capacity to deglycosylate host glycoproteins and a lack of
oxidase activity3. Since the description of the C. canis
species in 20153, only a few cases of human infection from
C. canis have been reported in the literature. However, a
C. canis strain was isolated from a cat wound, and another
C. canis was recently reported to cause a human septi-
cemia4,5. It was, thus, not totally unexpected to find some
Table 4 Capsular typing of C. cynodegmi isolates
Strain PCR typing WB typing
ABC A B C D E Serovar A B C D E F G H I L M Serovar
Human
strains
G14 − − − − − − nt − − − − − − − − − − − nt
G25 − − − − − − nt − − − − − − − − − − − nt
G55 + − + − − − B − + − − − − − − − − − B
G78 + − + − − − B − + − − − − − − − − − B
G84 − − − − − − nt − − − − − − − − − − − nt
G89 − − − − − − nt − − − − − − − − − − − nt
G107 + − + − − − B − + − − − − − − − − − B
G122 − − − − − − nt − − − − − − − − − − − nt
G123 − − − − − − nt − − − − − − − − − − − nt
Ccy4 − − − − − − nt − − − − − − − − − − − nt
Dog
strains
Gd02 − − − − − − nt − − − − − − − − − − − nt
Gd12 − − − − − − nt − − − − − − − − − − − nt
Gd13 − − − − − − nt − − − − − − − − − − − nt
Gd14 − − − − − − nt − − − − − − − − − − − nt
Gd16 − − − − − − nt − − − − − − − − − − − nt
Gd17 − − − − − − nt − − − − − − − − − − − nt
Ccy1 − − − − − − nt − − − − − − − − − − − nt
Ccy19 − − − − − − nt − − − − − − − − − − − nt
Ccy46 − − − − − − nt − − − − − − − − − − − nt
Ccy74 − − − − − − nt − − − − − − − − − − − nt
Ccy121 − − − − − − nt − − − − − − − − − − − nt
Ccy118 − − − − − − nt − − − − − − − − − − − nt
Ccy110 − − − − − − nt − − − − − − − − − − − nt
Ccy113 − − − − − − nt − − − − − − − − − − − nt
Ccy281 − − − − − − nt − − − − − − − − − − − nt
Ccyn2B − − − − − − nt − − − − − − − − − − − nt
Capsular typing was determined by PCR using the oligonucleotides given in Supplementary Table S2. The results were interpreted as described previously14: strains
positive for PCR A, PCR A and PCR B or PCR A and PCR C were typed as A, strains positive for only PCR B were typed as B, and strains positive for only PCR C as C.
Western blot analysis on polysaccharidic structures was performed using specific polyclonal rabbit antisera. nt non-typable
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C. canis among the CCUG collection of clinical strains,
although their limited number (6) compared to that of
C. canimorsus (96) indicates that C. canis is much less
involved in human infections than is C. canimorsus.
The C. canis strains previously isolated from human
infections were both oxidase-positive4,5, differing from the
majority of C. canis strains found in dog mouths3.
Among the six C. canis strains of the CCUG collection,
we found two that were oxidase-positive, supporting the
hypothesis that oxidase-positive C. canis strains are more
virulent to humans than strains lacking this activity. We
found one C. canis strain to be endowed with a serovar B
capsule. This observation is of great interest, because it
shows for the first time that this capsular serovar is not
restricted to the C. canimorsus species. In addition, we
identified four dog-isolated C. canis strains belonging to
capsular serovar A and one isolate belonging to the F
serovar, showing that several C. canimorsus serovars are
present in the closely related C. canis species. We found
11.7% of dog-isolated C. canis belonging to the A serovar,
indicating that this serovar is even more frequent in
C. canis than in dog-isolated C. canimorsus (1.9%). In
contrast, among the six human-isolated C. canis strains,
we could not find any serovar A strain. Considering the
limited number of clinical C. canis strains analyzed, we
cannot draw any definitive conclusion, but we can hypo-
thesize that, in C. canis, capsular serovar A strains are not
more virulent than other serovars, as is the case for
C. canimorsus. The same conclusion cannot be drawn for
serovar B C. canis, which we found in one clinical isolate
but not in dog-isolated C. canis. Most C. canis strains
could not be typed with the 11 sera we generated, sug-
gesting that, as in C. canimorsus, there is a large reservoir
of capsular serovars in C. canis. In line with this
hypothesis, we note C. canis strains G36 and G77, which
are positive for PCR ABC but do not belong to the A, B,
and C serovars. Their genomes likely encode the wfdR
glycosyl transferase detected by the ABC PCR but not one
or more genes that determine the A, B, or C capsular
serovars.
Whether some C. canis serovars might be more virulent
to humans remains unknown and will require further
investigation.
The finding of C. canis strains having similar capsules as
C. canimorsus raised the question as to whether the other
closely related dog-hosted species, C. cynodegmi, might
also have capsules with similar epitopes. Interestingly, the
typing of 10 human-isolated C. cynodegmi strains revealed
the presence of three serovar B strains, indicating that
this capsular serovar is not restricted to the C. canimorsus
and C. canis species. Among the dog-isolated C. cyno-
degmi strains, none could be typed with our 11 sera. The
finding of 3 of 10 (30%) C. cynodegmi strains of serovar B
among clinical isolates and none among dog isolates
suggests that C. cynodegmi endowed with a B capsule is
more virulent to humans (Fisher’s exact test with a sig-
nificance level of p < 0.05, p= 0.0462). As stated before,
these conclusions should be taken with caution, con-
sidering the limited number (26) of C. cynodegmi strains
analyzed in this study.
In conclusion, our study confirms that C. canimorsus
strains belonging to serovars A, B, and C are more viru-
lent to humans than other strains. Since these serovars
represent a low percentage of dog-isolated strains, we can
infer that few dogs carry these dangerous strains. This
conclusion is of great importance, because it contributes
to an explanation for the paradox of the low incidence of
the disease in spite of the abundance of dogs carrying
C. canimorsus. This conclusion is important for the pre-
vention of the disease, because the PCR test we have
developed could be adapted to identify potentially more
dangerous dogs, keeping in mind, however, that some
C. canis strains do harbor an A capsule and some C.
cynodegmi strains harbor a B capsule. A real-time PCR
test could be developed, for example, to detect virulent
Capnocytophaga strains directly in dog saliva samples.
A step forward would then be to eradicate the strains
from these animals, leading to a significant reduction in
pathogen shedding and, finally, in human infections.
Furthermore, we show, for the first time, that several
capsular serovars (A, B, and F) are shared by the three
dog-hosted Capnocytophaga species. The commonality
of some capsular serovars in these three species might
result from genetic transfers of the capsular genes. This
hypothesis is supported by the genetic organization of the
C. canimorsus capsular genes, which are organized in
loci including genes coding for transposases13. Whether
Capnocytophaga species exchange their capsular genes is
an open question that requires further investigation.
Materials and methods
Bacterial strains and growth conditions
The C. canimorsus, C. canis, and C. cynodegmi bacterial
strains used in this study are listed in Supplementary
Table S1. For serotyping, bacteria were grown on heart
infusion agar (BD Difco, Franklin Lakes, NJ, USA) plates
supplemented with 5% sheep blood (Oxoid, Basingstoke,
UK) and 20 µg/ml gentamicin (Sigma-Aldrich, Darmstadt,
Germany) and incubated for 48 h at 37 °C with 5% CO2.
Species identification by 16S rDNA sequencing
For 16S rRNA gene (16S rDNA) amplification by PCR, a
single colony was resuspended in 100 µl ddH2O and
heated for 10min at 98 °C. One microliter was used as
template for amplification of a 1.07 kb fragment of the 16S
rDNA. The primers 27F and 1100R (Supplementary
Table S2) were used at 0.4 mM concentration with
200mM dNTP and 1 U Taq polymerase (NEB, Ipswich,
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MD, USA). PCR was carried out for five initial cycles
(94 °C for 30 s, 60 °C for 2 min, 72 °C for 3 min), in which
the annealing temperature was reduced by 1.5 °C/cycle,
followed by 30 cycles (94 °C for 30 s, 52 °C for 90 s, 72 °C
for 3 min) and a final elongation for 10 min at 72 °C. The
1.07 kb PCR product was extracted from a 1.2% agarose
gel by NucleoSpin (Macherey Nagel, Düren, Germany).
The cleaned PCR products were sequenced by Eurofins
Genomics with the primers 27F, 685R, and 1100R (ref. 15
and ref. 16) (Supplementary Table S2). The consensus
sequences were obtained using BioEdit software and
then used to build a 16S phylogenetic tree using the
Ribosomal Database Project Tree Builder tool (http://rdp.
cme.msu.edu/).
Antiserum production and adsorption
Anti-A to anti-I antiserum production is described in
ref. 14. Rabbit polyclonal sera anti-L (strain G06) and anti-
M (strain G58) and anti-G45 strain were prepared like-
wise according to ref. 14. Immunizations were performed
at the Centre d’Economie Rurale (CER Groupe, Aye,
Belgium). The CER animal welfare committee approved
the animal handling and procedures. Sera were then
adsorbed with a mix of 25 strains isolated from patients
(Cc1 to Cc25, Supplementary Table S1) to obtain poly-
clonal antibodies specifically recognizing the capsular
serovars against which the sera were raised. Adsorptions
were performed by incubating 250 µl of antiserum with
6 × 109 PFA-fixed bacteria on a rotating wheel at room
temperature for at least 2 h. Bacteria were removed by
successive centrifugations. The incubation and following
centrifugations were repeated four times.
ELISA
Capsular typing of Capnocytophaga strains by PCR,
Western blotting and ELISA was performed as described
in ref. 14.
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